Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17869635 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
Conditions: Thromboembolism;   Arthroplasty, Replacement, Hip
Interventions: Drug: dabigatran etexilate;   Drug: enoxaparin

Indicates status has not been verified in more than two years